AZITRA INC (AZTR) Fundamental Analysis & Valuation
NYSEARCA:AZTR • US05479L3024
Current stock price
0.2345 USD
-0.01 (-3.1%)
At close:
0.2385 USD
+0 (+1.71%)
After Hours:
This AZTR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AZTR Profitability Analysis
1.1 Basic Checks
- AZTR had negative earnings in the past year.
- In the past year AZTR has reported a negative cash flow from operations.
- In the past 5 years AZTR always reported negative net income.
- AZTR had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -218.00%, AZTR is doing worse than 89.36% of the companies in the same industry.
- With a Return On Equity value of -288.21%, AZTR is not doing good in the industry: 73.31% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -218% | ||
| ROE | -288.21% | ||
| ROIC | N/A |
ROA(3y)-195.64%
ROA(5y)-172.43%
ROE(3y)-293.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AZTR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. AZTR Health Analysis
2.1 Basic Checks
- AZTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AZTR has been increased compared to 1 year ago.
- The number of shares outstanding for AZTR has been increased compared to 5 years ago.
- The debt/assets ratio for AZTR is higher compared to a year ago.
2.2 Solvency
- AZTR has an Altman-Z score of -23.96. This is a bad value and indicates that AZTR is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -23.96, AZTR is doing worse than 86.07% of the companies in the same industry.
- A Debt/Equity ratio of 0.05 indicates that AZTR is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.05, AZTR is in line with its industry, outperforming 41.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -23.96 |
ROIC/WACCN/A
WACC9.23%
2.3 Liquidity
- AZTR has a Current Ratio of 2.83. This indicates that AZTR is financially healthy and has no problem in meeting its short term obligations.
- AZTR has a worse Current ratio (2.83) than 65.76% of its industry peers.
- AZTR has a Quick Ratio of 2.83. This indicates that AZTR is financially healthy and has no problem in meeting its short term obligations.
- AZTR's Quick ratio of 2.83 is on the low side compared to the rest of the industry. AZTR is outperformed by 63.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.83 | ||
| Quick Ratio | 2.83 |
3. AZTR Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 85.76% over the past year.
- Looking at the last year, AZTR shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)85.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.14%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- AZTR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.90% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.17%
EPS Next 2Y40.67%
EPS Next 3Y25.9%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. AZTR Valuation Analysis
4.1 Price/Earnings Ratio
- AZTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AZTR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- AZTR's earnings are expected to grow with 25.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.67%
EPS Next 3Y25.9%
5. AZTR Dividend Analysis
5.1 Amount
- No dividends for AZTR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AZTR Fundamentals: All Metrics, Ratios and Statistics
0.2345
-0.01 (-3.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-27 2026-02-27/amc
Earnings (Next)N/A N/A
Inst Owners2.1%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap3.80M
Revenue(TTM)N/A
Net Income(TTM)-10.96M
Analysts82.86
Price Target1.38 (488.49%)
Short Float %2.2%
Short Ratio0.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.56%
Min EPS beat(2)16.67%
Max EPS beat(2)38.46%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-50%
PT rev (3m)-50%
EPS NQ rev (1m)32.43%
EPS NQ rev (3m)32.43%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1 | ||
| P/tB | 1.09 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.25
EYN/A
EPS(NY)-1.14
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS0
BVpS0.23
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -218% | ||
| ROE | -288.21% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-195.64%
ROA(5y)-172.43%
ROE(3y)-293.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 17.52% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.83 | ||
| Quick Ratio | 2.83 | ||
| Altman-Z | -23.96 |
F-Score1
WACC9.23%
ROIC/WACCN/A
Cap/Depr(3y)14.84%
Cap/Depr(5y)136.79%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.14%
EPS Next Y99.17%
EPS Next 2Y40.67%
EPS Next 3Y25.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.22%
OCF growth 3YN/A
OCF growth 5YN/A
AZITRA INC / AZTR Fundamental Analysis FAQ
What is the ChartMill fundamental rating of AZITRA INC (AZTR) stock?
ChartMill assigns a fundamental rating of 1 / 10 to AZTR.
What is the valuation status for AZTR stock?
ChartMill assigns a valuation rating of 1 / 10 to AZITRA INC (AZTR). This can be considered as Overvalued.
What is the profitability of AZTR stock?
AZITRA INC (AZTR) has a profitability rating of 0 / 10.
What is the expected EPS growth for AZITRA INC (AZTR) stock?
The Earnings per Share (EPS) of AZITRA INC (AZTR) is expected to grow by 99.17% in the next year.